EX

Exponent, Inc.

EXPOIndustrialsNASDAQ

Engineering & Construction

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$582.0M
+4.2% YoY
Net Income
$106.0M
-2.7% YoY
EBITDA
$129.9M
+0.5% YoY
Free Cash Flow
$76.9M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Negative CrossoverHistogram -0.1260, negative momentum
Sep 2 MACD Negative CrossoverHistogram -0.0340, negative momentum
About Exponent, Inc.

Part of the industrials sector, Exponent, Inc. (EXPO) is listed under Engineering & Construction. The company carries a $3.25B market cap, placing it firmly in the mid-cap category. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.

Where EXPO stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, EXPO finished 7.95% above its 150-day moving average ($64.87) and 5.13% above its 200-day moving average ($66.61). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is EXPO overbought or oversold?

At the September 3, 2026 close, EXPO's RSI(14) was 58.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$3.25B
P/E (TTM)30.65
Fwd P/E24.09
EPS$2.23
Beta0.69
52W Change-3.7%
Dividend Yield1.80%
ROE31.2%
Analysis

On the balance sheet, EXPO has $66.6M in cash with $80.7M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $76.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 31.2% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 11.3% further supports the picture of efficient asset utilization. Revenue has grown from $466.3M (2021) to $582.0M (2025), reflecting a 25% increase over the period.

EXPO's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing EXPO's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Industrials stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms